mProX™ Human VDR Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Nuclear Receptor
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Thomas
Verified Customer
Gary
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 CYP24A1 and VDR expression in NSCLC cell lines.
Expression of CYP24A1 and VDR in NSCLC cell lines in response to vitamin D analogs 1,25D3 and PRI-2191. Lung cancer cell lines were exposed to PRI-2191 and 100 nM 1,25D3 for ninety-six hours. The expression of VDR and CYP24A1 proteins was measured by western blot analysis.
Ref: Maj, Ewa, et al. "Differential response of lung cancer cell lines to vitamin D derivatives depending on EGFR, KRAS, p53 mutation status and VDR polymorphism." The Journal of steroid biochemistry and molecular biology 193 (2019): 105431.
Pubmed: 31326626
DOI: 10.1016/j.jsbmb.2019.105431
Research Highlights
This review of the literature aims to provide a current analysis of the function of the VD and VDR in the initiation, development, and prognosis of all cancer types.
Merchan, Borja Bandera, et al. "The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences." The Journal of steroid biochemistry and molecular biology 167 (2017): 203-218.
Pubmed:
27913313
DOI:
10.1016/j.jsbmb.2016.11.020
The nuclear receptor vitamin D receptor (VDR) controls the biological activities of 1,25-dihydroxyvitamin D3. In the gut, VDR expression is highly expressed. Immunity, barrier function, and intestinal cell proliferation are all crucially regulated by VDR.
Bakke, Danika, and Jun Sun. "Ancient nuclear receptor VDR with new functions: microbiome and inflammation." Inflammatory bowel diseases 24.6 (2018): 1149-1154.
Pubmed:
29718408
DOI:
10.1093/ibd/izy092